There is an effective cure for Ebola
Clinical trials and regulatory approvals confirm that specific monoclonal antibody treatments, such as REGN-EB3 and mAb114, are effective in treating Ebola virus disease and significantly reducing mortality.
The retrieved literature contains multiple high-quality sources, including randomized controlled trials and systematic reviews, demonstrating that targeted monoclonal antibody treatments (such as Ansuvimab, mAb114, and REGN-EB3) are effective therapies that significantly reduce mortality in Ebola virus disease. There are no papers refuting the existence of effective treatments.
Diane S. Aschenbrenner. Monoclonal Antibody Approved to Treat Ebola. 2021. https://doi.org/10.1097/01.naj.0000742484.81331.b2
Ansuvimab-zykl (Ebanga) is an approved human monoclonal antibody used to treat Zaire ebolavirus infection.
See more details
Sabue Mulangu, Lori E Dodd, Richard T Davey, Olivier Tshiani Mbaya, Michael Proschan, Daniel Mukadi, Mariano Lusakibanza Manzo, Didier Nzolo, Antoine Tshomba Oloma, Augustin Ibanda, Rosine Ali, Sinaré Coulibaly, Adam C Levine, Rebecca Grais, Janet Diaz, H Clifford Lane, Jean-Jacques Muyembe-Tamfum, Billy Sivahera, Modet Camara, Richard Kojan, Robert Walker, Bonnie Dighero-Kemp, Huyen Cao, Philippe Mukumbayi, Placide Mbala-Kingebeni, Steve Ahuka, Sarah Albert, Tyler Bonnett, Ian Crozier, Michael Duvenhage, Calvin Proffitt, Marc Teitelbaum, Thomas Moench, Jamila Aboulhab, Kevin Barrett, Kelly Cahill, Katherine Cone, Risa Eckes, Lisa Hensley, Betsey Herpin, Elizabeth Higgs, Julie Ledgerwood, Jerome Pierson, Mary Smolskis, Ydrissa Sow, John Tierney, Sumathi Sivapalasingam, Wendy Holman, Nikki Gettinger, David Vallée, Jacqueline Nordwall. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.. 2019. https://doi.org/10.1056/NEJMoa1910993
A randomized controlled trial demonstrated that monoclonal antibody therapies such as MAb114 and REGN-EB3 are effective in reducing mortality from Ebola virus disease.
Ya Gao, Yunli Zhao, Gordon Guyatt, Robert Fowler, Richard Kojan, Long Ge, Jinhui Tian, Qiukui Hao. Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis.. 2022. https://doi.org/10.1016/S2666-5247(22)00123-9
A systematic review and network meta-analysis confirmed that treatments like REGN-EB3 and mAb114 significantly reduce mortality in patients with Ebola virus disease compared to standard care.
Deniz Güllü, Şiran Keske, Önder Ergönül. Viral hemorrhagic fevers - therapeutic trial advances and challenges.. 2025. https://doi.org/10.1080/14787210.2025.2592294
Recent therapeutic advancements include monoclonal antibodies for Ebola virus disease that have demonstrated clinical efficacy.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt